Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gattex in PN-dependent Short Bowel Syndrome (STEPS-2)
NCT00930644Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Sep 2009; status: completed.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT00930644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00930644.